A Clinical Study Evaluating the Safety and Efficacy of IDP-115 in Patients With Rosacea - Contacts and Locations

A Clinical Study Evaluating the Safety and Efficacy of IDP-115 in Patients With Rosacea

This study has been completed.

Study NCT00667173. Last updated on July 29, 2008. Information provided by Dow Pharmaceutical Sciences

Please refer to this study by its ClinicalTrials.gov identifier: NCT00667173

Locations


United States, Alabama
	Medical Affiliated Research Center, Inc.
	Huntsville, Alabama, United States, 35801

United States, California
	Solano Clinical Research
	Vallejo, California, United States, 94589
	Therapeutics Clinical Research
	San Diego, California, United States, 92123

United States, Colorado
	Cherry Creek Dermatology Research Inc.
	Denver,, Colorado, United States, 80246

United States, Florida
	FXM Research Corp.
	Miami, Florida, United States, 33175

United States, Georgia
	MedaPhase Inc.
	Newnan, Georgia, United States, 30263

United States, Michigan
	Henry Ford Medical Center
	Detroit, Michigan, United States, 48202

United States, New Mexico
	Academic Dermatology Associates
	Albuquerque, New Mexico, United States, 87106

United States, Ohio
	University Dermatology Consultants, Inc.
	Cincinnati, Ohio, United States, 45219

United States, Texas
	DermResearch, Inc.
	Austin, Texas, United States, 78759

Sponsors and Collaborators

Dow Pharmaceutical Sciences